Filing Details
- Accession Number:
- 0001651844-16-000015
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-04-15 18:16:54
- Reporting Period:
- 2016-04-11
- Filing Date:
- 2016-04-15
- Accepted Time:
- 2016-04-15 18:16:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1018735 | Nymox Pharmaceutical Corp | NYMX | In Vitro & In Vivo Diagnostic Substances (2835) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1651844 | George James Robinson | 10 East Lee Street Suite 2705 Baltimore MD 21202 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-04-11 | 4,500 | $2.53 | 2,722,550 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2016-04-11 | 4,500 | $2.49 | 2,727,050 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2016-04-12 | 4,500 | $2.45 | 2,731,550 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2016-04-12 | 3,000 | $2.45 | 2,734,550 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2016-04-12 | 3,000 | $2.40 | 2,737,550 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2016-04-13 | 5,000 | $2.32 | 2,742,550 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2016-04-13 | 5,000 | $2.19 | 2,747,550 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2016-04-15 | 3,500 | $2.39 | 2,751,050 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2016-04-15 | 3,000 | $2.37 | 2,754,050 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2016-04-15 | 3,500 | $2.39 | 2,757,550 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 45,050 | Indirect | Trust |
| Common Stock | 45,050 | Indirect | Trust |
| Common Stock | 45,050 | Indirect | Trust |
| Common Stock | 45,050 | Indirect | Trust |
| Common Stock | 45,050 | Indirect | Trust |
| Common Stock | 45,050 | Indirect | Trust |
| Common Stock | 45,050 | Indirect | Trust |
| Common Stock | 45,050 | Indirect | Trust |
| Common Stock | 45,050 | Indirect | Trust |
| Common Stock | 45,050 | Indirect | Trust |
Billionaire Hedge Funds
